Toenail topical shows efficacy in trials

A topical antifungal manufactured by Palo Alto, CA-based Ancor Pharmaceuticals clears nails and fungal infection in people with onychomycosis, according to data presented in July at the 2013 American Podiatric Medical Association Annual Scientific Meeting held in Las Vegas. Max Weisfeld DPM, a podiatrist in private practice in Baltimore, MD, reported on results of two phase 3 trials of tavaborole that showed the boron-based agent cleared nails and cured fungal infection in about 27% and 35% of study participants, respectively

Continue Reading:
Toenail topical shows efficacy in trials

Previous post:

Next post: